CANSINOBIO: VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE I/II CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT IN PHASE I CLINICAL TRIAL FOR RECOMBINANT POLIOMYELITIS VACCINE IN INDONESIA
CANSINOBIO: VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE II/III CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT IN PHASE II CLINICAL TRIAL FOR TDCP ADOLESCENT AND ADULT
CANSINOBIO: Overseas regulatory announcement.
CANSINOBIO: Overseas regulatory announcement.
CANSINOBIO: VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR DTCP INFANT
CANSINOBIO: INSIDE INFORMATION - CHANGE OF INTERESTS OF PARTIES ACTING IN CONCERT
CANSINOBIO: Overseas Regulatory Notice
CANSINOBIO: Monthly Return of Equity Issuer on Movements in Securities
CANSINOBIO: VOLUNTARY ANNOUNCEMENT - ANNOUNCEMENT ON THE 2024 INVESTOR OPEN DAY EVENT
CANSINOBIO: VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF THE SUPPLEMENTAL DRUG APPLICATION FOR MENHYCIA
CANSINOBIO: Overseas Regulatory Notice
CANSINOBIO: CHANGE OF EMPLOYEE REPRESENTATIVE SUPERVISOR
CANSINOBIO: Overseas Regulatory Notice
CANSINOBIO: VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE I CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT FOR HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE, FREEZE-DRIED
CANSINOBIO: Monthly Return of Equity Issuer on Movements in Securities
CANSINOBIO: VOLUNTARY ANNOUNCEMENT - RECOMBINANT POLIOMYELITIS VACCINE OBTAINS CLINICAL TRIAL APPROVAL IN INDONESIA
CANSINOBIO: VOLUNTARY ANNOUNCEMENT - GRANT AGREEMENT OF RECOMBINANT POLIOMYELITIS VACCINE AND RELATED COMBINED VACCINE PROJECT
CANSINOBIO: Monthly Return of Equity Issuer on Movements in Securities
CANSINOBIO: Overseas Regulatory Notice
CANSINOBIO: Monthly Return of Equity Issuer on Movements in Securities